# Methylphenidate Treatment Response Study of Genetic Polymorphism in Attention Deficit Hyperactivity Disorder(ADHD)

> **NCT00862108** · PHASE4 · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Attention Deficit Hyperactivity Disorder

## Interventions

- **DRUG:** Methylphenidate

## Key facts

- **NCT ID:** NCT00862108
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-09
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2009-09-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00862108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00862108, "Methylphenidate Treatment Response Study of Genetic Polymorphism in Attention Deficit Hyperactivity Disorder(ADHD)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00862108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*